Beckman Coulter (BC) is a manufacturing company that develops clinical Diagnostic products and clinical laboratory solutions. The main vision of the company is to deliver faster and smarter Diagnostic solutions for the medical industry that "move the needle forward from what's now to what's next” (Beckmancoulter.com, 2023). It is important in the medical industry to apply the power of science to enhance the treatment and accelerate the performance of medical practitioners. Their mission is "to relentlessly reimagine Healthcare one diagnosis at a time" (Beckmancoulter.com, 2023). The company has committed towards the people process and solution that can help clinical Laboratories and health care networks provide an advantage in patient care. The strategic objectives of the company highlights
“Accelerating the cure with a menu that matters”
Achieving the” benefit of automation”
Delivering “deeper insights through the information technology”
Adding “hidden value through the performance partnership”
Figure 1: Beckman Coulter
These are the main strategic objectives of Beckman Coulter mainly trying to achieve profitability and improve operational efficiency. The Diagnostic solution of the company is mainly used in different Complex clinical testing for hospitals reference Laboratories and physician office settings across the world. The medical company provides a wide range of clinical menus with automation technology and clinical Informatics that can help to optimise laboratory performance. More than 11,000 employees work in Beckman Coulter across the world which is helpful to discover various innovative solutions (Linkedin.com, 2023). Using global talents, Beckman has achieved the leading competitive position across the industry. The annual revenue of the company is $3.7 billion which is achieved by operating across the US, Europe, Canada and Asia (Labmate-online.com, 2023). In this way, the company is trying to achieve competencies in the diagnostics industry.
Current Business Scenario
Evaluating organisational design
Organisational design and structure are essential in order to maintain operation in an effective manner in changing the Marketplace. B&C has a hierarchical structure that includes executive leadership, business units, departments and other employees. The organisation has a Matrix structure which is complete in the industry and involves employees belonging to both functional departments and product teams for managing flexibility in operation. As stated by Kretschmer et al. (2022), having a complex structure in an organisation can often create challenges in communication for employees. However, Beckman Coulter company operates across the world among different countries with regional managers in specific areas. Suzanne Foster is the president and Adam Mandelbaum is the vice president and general counsel of the company. Sister life science companies are Aldevron, Cytiva, IDBS, SCIEX, PALL and others.
Figure 2: Sister companies
Discussing external business competitors and organisational performance
The external performance of the company has been understood with the number of operated regions and a number of sister companies. The company has also implemented a total quality system to accelerate laboratory efficiency. Though there are various other competitors such as Roche Diagnostics, Siemens, Abbott, and Tharmo Fisher, the innovativeness and performance of Beckman Coulter has achieved leadership in the market.
Environmental Analysis
Since Beckman Coulter is a part of the medical diagnostics sector, its operations and profitability are very susceptible to shifts in the economy, regulations, and technology. Trends in healthcare expenditure and government regulations are two critical external elements that affect the company's operations and financial performance. The company's potential is directly shaped by government rules, particularly those about product approvals and reimbursement schemes. For instance, the capacity to introduce advances in that market is delayed when a nation's regulatory body imposes stricter approval procedures for new diagnostic tests. Operating costs are also increased by adhering to various foreign rules (Ribeiro and Kruglianskas, 2020).
Furthermore, adjustments to government healthcare programs as well as insurance policies that lower laboratory test reimbursement rates have a detrimental effect upon the company’s profit margins and capacity to increase sales in that market. The growth potential of the organisation is also significantly impacted by trends in healthcare spending and policy. For example, the Affordable Care Act's expansion of health insurance coverage in the United States has increased access to and use of clinical lab testing increasing income for the diagnostics sector (Zhao et al., 2020). Nevertheless, despite increasing test volumes, Beckman's sales potential has decreased due to recent slower growth in national healthcare budgets, hospital capital budget reductions, and healthcare network mergers. These developments have placed a financial burden on providers. This demonstrates how external macroenvironmental changes in healthcare spending may help or hurt a company's ability to achieve its goals. The company has responded to these significant external challenges with several calculated moves. The firm has concentrated its R&D expenditure on rapidly expanding, more stable industries like immunoassay testing to mitigate market volatility by shifting government rules and reimbursement rates. Beckman has also made significant investments in developing nations, taking advantage of the increased access to healthcare in areas like Asia Pacific (World Benchmarking Alliance, 2020).
To help hospitals and labs with their limited resources, Beckman has also actively sought collaborations, acquisitions, and product bundles. In recent years, the firm has acquired product lines from Abbott Labs and Sysmex for nearly $1.6 billion to increase its global client base (Gupta, 2022). A closer look at the firm's external operating environment shows that the firm faces both possibilities and dangers from technological change, regulations, and healthcare spending. With the advent of point-of-care testing, automation, and precision medicine, the diagnostics sector is rapidly modernizing. With cutting-edge platforms, these technology-driven changes give non-traditional rivals and new market entrants greater leverage. Adapting goods and sales tactics to stay up might impact operating margins for established firms like Coulter's since it involves more R&D expenses (Frankenfield, 2019).
Grab The Best Academic Assistance In Just One Click
Nonetheless, technological advancements also facilitate top-line development by making it possible to identify additional illness biomarkers and customize therapies according to clinical lab data. Regarding Beckman specifically, new technologies are making it easier for automated chemistry and immunoassay testing to come together on integrated in-vitro diagnostic systems. Furthermore, Coulter's collaboration with Diagnostic Robotics to introduce AI-based clinical decision assistance to laboratories demonstrates adaptability to automation and data analytics (Mosch et al., 2022). However, there is still a risk from competitors offering more affordable and practical point-of-care options. To bring cutting-edge automated technologies to market more quickly in the future, the firm will have to quicken its product development. The organization must also expand IT skills to utilize digital health data properly. Incorporating AI tools into portfolios to detect and track diseases sooner might increase lab value and help maintain its market share even as the industry changes (Choi et al., 2022). The operational footprint and profitability of Coulter are significantly impacted by legislation and developments in healthcare spending. Environmental variables such as stricter regulations drive up costs and prolong approval delays, while quicker market expansion is made possible by supporting policies and increased testing volumes.
Strategy Identification and Implementation
Strategy Identification at Beckman Coulter, Inc.
At the cutting edge of the biomedical assessment business is Beckman Coulter, Inc., a Danaher Corporation affiliate that focuses on the study, manufacture, and commercialization of equipment that optimizes, facilitates, and modernizes complicated procedures for testing. A planning process is crucial for propelling a company to fresh levels by encouraging technology in a variety of market disciplines. Building an extensive firm strategy involves employing and thoroughly evaluating competitive equipment.
Strategy Formulation Tools
The Ansoff Matrix is an advantageous instrument for this healthcare corporation, Inc. to come up with approaches. Igor Ansoff designed this Matrix, which explores four strategies regarding advancement: diversification, creating goods, penetration of markets, and market expansion (Terracciano et al., 2022). With respect to both danger and reward, every section presents a unique plan for establishing the organization.
A greater effort inside present-day markets is an initial option. Utilizing this method, the healthcare giant could expand its share of the marketplace by conducting strong advertising efforts, developing keeping customers' efforts while searching for fresh possibilities for transmission. This would promote diversification in established industries by leveraging the enterprise's actual products and amenities. Market expansion has brought contemporary goods into fresh marketplaces. Considering its knowledge of biomedical evaluation, the firm (BC) could investigate undiscovered locales or groups of individuals (Hoffmann et al., 2023). The firm may expand its audience while creating an international footprint by personalizing its service range to satisfy the distinctive demands of these various areas. The above plan aims to break into unfamiliar markets with novel offerings. Becoming an expert in creative thinking, Beckman might invest funds in discovery and development in order to offer breakthrough clinical diagnostic technologies. In spite of remaining forward of the concurrence, the Corporation is going to be equipped to keep up with the fluctuating expectations of its present customers by introducing novel items that deal with new phenomena and problems in the medical sector (Islam et al., 2022). The most risky approach is expansion, but it comes with the highest possibility of profitability. Beckman Coulter's shareholders might be considering launching new items or offerings into untapped marketplaces. This could mean extending out into various aspects of the medical field or researching various industries wherever the business's technical knowledge can be deployed (Tzovara et al., 2022). Specialization structures the enterprise and functions as a hedge contrary to fluctuating markets. It is always a useful instrument for creating methods, although it's essential to remember that the healthcare research field is flexible. The rapidly developing of inventions in conjunction with shifting medical demands necessitates an increasingly versatile and adaptable technique (Otsu et al., 2023). This Matrix is capable of being supplemented with Bowman's Strategy Clock, delivering a greater awareness of competitors' stances and distinctive characteristics.
Cliff Bowman and David Faulkner innovated beyond regular cost management and distinction ways through their design of the Strategy Clock by Bowman. It promotes an elegant outlook on business competitiveness by implementing composite techniques that maintain an acceptable equilibrium across significance and pricing. The aforementioned instrument can be beneficial for the firm to examine its present-day tactical position extensively and discover issues that would like adjustment (Bonifay et al., 2022). The operation can, for instance, emphasize a " Concentrated Distinctiveness" policy by delivering exceedingly detailed medical research. Diagnostics regarding specific ailments or targeted markets. This plan of action might acquire a distinctive competitive advantage and coincide with The researcher's passion for creativity for this branded company.
Figure 5: Browman’s Strategy Clock
Similar to how fundamental planning is a fruitful execution of planning. All divisions should be centred, and the leadership team needs to foster an inventive and adaptable workplace. This entails making spending on training for workers, increasing interconnected partnerships, and applying automation to hurry up workflows. Persistent evaluation and input processes are also recommended to determine how the techniques are operating. In order to arrive at prudent choices, KPIs (key performance indicators) relating to merchandise creative thinking, market penetration, and client retention must be analyzed frequently (Khiong, 2022). In order to sum up, the strategy clock devised by Bowman and the Matrix designed by Ansoff is a couple of elements which have been methodically implemented throughout the methodical strategy formulation and execution course at the reputed brand. With the implementation of the aforementioned values and encouragement of the development of an adaptable and creative tradition, Beckman may cement its spot as the benchmark in the clinical diagnostics category, ensuring continual progression along with superior medical services.
Strategy Implementation for Beckman Coulter, Inc.
A popular operator in the clinical research category, Beckman Coulter, Inc. represents an affiliate of Danaher Corporation, which specializes in creating, producing, and exporting items that optimize, facilitate, and reinvent complicated methods. A strategy's efficient execution is vital to an entity's capacity to evolve and prosper as time goes on. A comprehensive blueprint for popular Corporations's tactical execution becomes crucial in this circumstance.
Implementation Plan
The overarching goals of the Danaher Corp need to be effortlessly integrated with BC's plan of action. In order to ensure that each staff member in the institution is made aware of the objective and how they can assist in implementing it, an in-depth interaction plan must already exist. Appropriate human and material assets should be dedicated to help strengthen the technique (Singh et al., 2023). This comprises support for recruiting workers, technological advances, and learning & progress. For guaranteed appropriate usage, the timeline for execution ought to define how those assets will be assigned among different divisions. Incorporating innovative technologies is of the utmost importance, provided the physical characteristics of their services. A framework for combining the latest innovations within statistical analysis, production processes, and creating goods ought to constitute a component of the policy. This is going to keep its position at the epicentre of inventiveness, boost productivity, and conserve funds. The scheme for enlarging the sector needs to be stated clearly in the overall approach. It involves determining fresh territories to branch out and then diversifying into comparable industries and commodities. A concentrated plan that takes into consideration local laws and marketplace trends will be essential to accomplishment (Belkina et al., 2023). Performance at Beckman Coulter Limited is contingent upon its personnel's competence and expertise. Activities for team members' continued growth and advancement ought to be included within an execution roadmap. Development workshops, chances to participate in instruction, and a working environment focussed on productivity will ensure that those working there can confront the campaign's setbacks.
Critical Success Factors
The capability of the Corporation to remain creative is integral to its prosperity. The passion of managers to create a climate of creativity is an essential aspect of accomplishment. This includes fostering a willingness to take risks, praising new ideas, and dedicating finances to scientific discovery. The clinical evaluating business is regulated by its users. The amount whereby the pharmaceutical business meets or surpasses client demands will define its effectiveness (Lemoine et al., 2022). The rollout of survey systems is an essential part of achievement as it provides the inclusion of patient views into the entire procedure for producing forthcoming goods and delivering offerings. It must be possible to be prepared to react rapidly to developments in market conditions. Perhaps the greatest crucial element of achievement is an adaptable organizational design that is underpinned by adjustable protocols and swift choices. As a consequence, Beckman Coulter's management will soon be positioned to adjust immediately to altering client needs and marketplace patterns (Chalke et al., 2022).
Change Readiness
The path chosen by Beckman Coulter to succeed is bound to result in modifications in several of its organizational components. A complete plan for managing change ought to be prepared and executed by an operation to ensure transformation preparation. Whenever situations fluctuate, it's crucial to express oneself in a straightforward way. The schedule must outline whether communication will be conveyed at every level in the organization concerning the overall plan, what it seeks, and its progression. Professionals should come trained to have the capacities and understanding required to adapt to freshly introduced techniques and technological innovations. In order to fill deficiencies in skills and offer staff the capabilities required to thrive in a changing environment, programmes for training and growth deserve to be implemented.
Promoting Innovations
Inspiring breakthroughs will be contingent on the setting up of specialized spaces for brainstorming and interaction. Beckman Coulter (BC) is capable of setting up discussions and teams across departments where individuals may discuss opinions and offer imaginative changes. A powerful reward structure must be put in place in order to motivate creation. Organizations that substantially influence progress might entail job development possibilities, compensation, or recognized campaigns (AYYILDIZ et al., 2022).
Figure 6: Promoting Innovations
To wrap things up, the effective execution of the famous enterprise's method involves a calculated blueprint that is in keeping with the Danaher Corporation's larger objectives. When safeguarding organization efficiency and exceeding client demands, key achievement specifications, changes, willingness, and a spotlight on pushing technologies are fundamental. By meticulously carrying out the aforementioned strategy, Beckman Coulter Pharmaceuticals will be characterized as an expert in the diagnostic verification area, stimulating robust growth and promoting a climate of creativity (Saw and Ng, 2022).
Leadership Styles to Manage Strategic Change
Leadership Styles and Organizational Performance
Throughout its executive history, Beckman Coulter has used transactional and transformational leadership techniques to foster development and generate substantial financial returns, particularly as the business has changed and grown. In particular, the organization has found success using a transactional approach that emphasizes incentives and direction with transformational elements like inspiration and vision. Arnold O. Beckman, the chairman of the organisation, has embodied strong goal-driven transactional leadership in the more than 85 years since the company was founded (Beckman, 2019). He put in place strong management procedures and systems to guarantee that the scientific equipment produced by the firm would be profitable. Coulter inspired staff members by establishing explicit KPIs linked to financial incentives. Over twenty years of consistent profitability were achieved with this transactional focus on measurement, responsibility, and ambition. However, just as important was the company’s idea to allow wider uses of the business's technology to revolutionize laboratory testing. Ultimately, this revolutionary perspective resulted in the introduction of automated clinical diagnostic tools capable of conducting chemical tests at significantly higher throughput. In uncertain times when the path to diversification was not evident, Beckman guided the organization toward this revolutionary goal. The company's development was reliant on this marriage of revolutionary insight and transactional efficiency. His focus on worker empowerment, stakeholder connections, and motivational communication was key to successfully introducing more than a dozen new testing products. However, uneven profitability resulted from prioritizing innovation over efficiency. Ultimately, Scott Garrett revived a transactional strategy focused on outcomes after becoming CEO. In addition, he persisted in his association, advocating for diversity and social responsibility. The CEO change at Coulter from Scott Garrett to Shantanu Jha provides insight into a successful hybrid leadership approach for the business moving ahead (The Wall Street Transcript, 2019).
Figure 7: Leadership Style
Jha assumed leadership during the exceptional COVID-19 pandemic, unsettling the diagnostics sector. His first strategy was stabilizing supply networks and internal processes to satisfy the rapidly increasing demand for testing. This indicated his earlier experience at Blackstone Group with transactional goals in private equity. Just as soon, though, Jha changed course and offered an encouraging picture of how the firm can influence healthcare access globally. He explained how early illness identification may improve patient outcomes through sustainable innovation. Jha has, therefore, deliberately struck a balance by combining a big-picture reform with an urgent transactional emphasis on execution. The ability of this adaptable leadership to prioritize both short-term gains and long-term goals will be crucial as Coulter strives to meet growth targets and make adjustments in response to a fast-changing healthcare environment (Anderson, 2020). The secret to maintaining market leadership will be the capacity to modify operations and strategy. According to Beckman Coulter's leadership background, transformational and transactional approaches may work well together when used in moderation. A lasting value is created when processes, change management, and inspiration are balanced in a way that allows for the pipeline of innovation through market volatility and profit constancy in the face of competition.
Leadership Styles and Values/ CSR
The formalized corporate values of The company place a strong emphasis on innovation, teamwork, excellence, honesty, and customer dedication. The leadership strategy has to keep advancing these principles in the face of change as the business expands into new markets and handles technological changes in the diagnostics industry. While guiding change and corporate social responsibility (CSR), combining transformational and participatory approaches can further establish company values; for the organization where stakeholder impact is important, transformational leadership that links daily operations to an inspirational mission is essential. Beckman's diagnostic technology impacts millions of lives; by explaining how it improves patient outcomes through early illness identification and monitoring, a transformational leader may reaffirm values like "innovation" and "commitment (VUCETIC, 2023)." Employees are proud of their societal effect on healthcare and are motivated to provide better products. In addition, a transformational approach emphasizes intellectual stimulation and talent coaching, which support the ideals of "excellence" and "teamwork." Around the "how," this motivation has to be backed by participative leadership. A gap between vision and execution may be avoided by incorporating feedback from end users, pilots, and cross-functional teams when shaping solution paths. Values-driven decision-making is facilitated by the comprehensive understanding of all stakeholders that participatory brainstorming delivers.
Figure 8: Beckman Coulter Value Commitment
Participatory innovation connects "excellence" and "commitment" with ethical business practices throughout the product life cycle, whether by introducing new automated immunoassay testing or adding AI-powered clinical analytics software. Clarity about priorities is provided, including accuracy, accessibility, and data protection. This facilitates collaboration on intricate issues across technological, commercial, sustainability, and legal teams. Studies on CSR and ESG reveal that collaborative leadership is five times more effective than demands for change made unilaterally (Mülbert and Sajnovits, 2022). Sustained participation is facilitated by open communication, collective responsibility in goal-setting, and acknowledgment.
Moreover, it permits course correction in response to consistent input. Young talent consultation, for instance, can reveal fresh directions for Beckman's CSR initiatives, such as promoting community health education or eco-friendly labs. Driving change via participation also helps avoid employee turnover due to being "left out" while handling significant acquisitions and integrating new cultures. Structured consultation overcomes communication gaps with actual conditions. Instead, leadership should emphasize how Coulter's mission and the need for change are connected, how to celebrate little victories, and how to lead teams through uncertainty. Transparency is a crucial component that increases the efficacy of mixed transformational and participatory leadership. Open and regular communication fosters trust, which inspires teams to overcome ambiguity. The executives of the firm must proceed to strategic goals and clarify company outcomes through frequent forums, transparent data, and real dialogues (Bernstein and Peterson, 2022). Employees may better understand the "why" behind change initiatives by being informed about the market environment and competitive dynamics that shape decisions. This promotes teamwork. Town halls, newsletters, and intranet postings, for example, that openly discussed integration objectives, deadlines, and anticipated advances encouraged teams to collaborate throughout the Luminex purchase.
Furthermore, openness necessitates proactively recognizing gaps and concrete facts even when the answers are not immediately apparent. When commands attempt to change without context, employees may eventually reject and become disengaged because they will start to doubt the reasoning behind it and feel left out. Worldwide events have highlighted how resonant leadership embraces flexibility while giving teams a trustworthy compass to help them navigate circumstances and advance important goals (Robertson, 2021). A variety of performance and cultural integrations can be guided by Beckman Coulter's leadership thanks to its inherent capabilities. The organization's potential will be realized more quickly if transparency is strengthened as the cornerstone of a transformative and participative change leadership style.
Recommendation
As an entity of Danaher Corporation(DC), Beckman Coulter(BC) plays a key role in the evolution of scientific diagnostics as a result of its imaginative design of goods, manufacture, and sales. A thorough set of proposals must be created for the management of strategy to be applied efficiently in an effort to go through the complicated terrain of the medical services sector and support sustained development. For continued success at the leading edge of inventiveness, the company ought to keep its unwavering commitment to investigating and technology. A regular supply of creative products to satisfy increasing hospital necessitate can be ensured by committing ample resources and qualified employees to pursue research and development (Turner et al., 2022). The range and breadth of the industrial's expertise in research may be additionally augmented by means of relations with research universities and business acquaintances. With the goal of capitalizing on the international requirement for specialized physiological diagnostic merchandise, Beckman Coulter & Company needs to set its sights on deliberate market penetration. This involves finding substantial regions with untapped value, modifying commodities to fit local specifications, and developing efficient channels of distribution (Chu et al., 2022). For promotional strategies to be profitable in worldwide marketplaces, they require being tailored to suit various cultural and institutional constraints. In contemporary clinical surroundings, electronic tools and solutions that depend on data are necessary. It would have been wise for the brand to contribute to initiatives to transform its business, including incorporating machine learning, AI, and sophisticated detectors into its products. This strengthens the brand's standing as an inspiration in the profession in the modern age of electronic healthcare and promotes the quality and efficacy of physiological monitoring. The skills and abilities of Beckman Coulter's personnel are inextricably dependent upon its overall profitability. Industries must invest in talent growth projects, regular education programmes, and an inviting place to work that will ensure an ongoing edge over the competition (Mahardhani, 2023). The best employees will be preserved in an extremely competitive profession with abundant workforce retention techniques such as favourable wages and prospects for upward mobility. The firm needs to rudely implement eco-friendly measures into its daily operations as community expectations on corporation accountability and ethical behaviour keep expanding. This involves utilizing cost-effective approaches, minimizing waste products, and developing ecologically conscious production processes. This certainly strengthens the image of the business but also matches the rising focus on ecology around the globe.
Conclusion
Acknowledging the necessity for alteration, Beckman Coulter Corp. executed an important environmental inspection whilst negotiating the complex arena of physiological diagnostics. The determination and use of approaches depended on this assessment. Successful change management is necessary as a result of the business's dedication to healthcare advancement, digitization, and reduction, thereby calling for a flexible executive strategy. The integration of modern facilities, technological advances, international expansion of markets, and environmentally friendly methods serve as essential considerations for this organization as it designs its destiny. At the interface of technological advancement and medical services, Beckman Coulter, Ltd. has an excellent chance for longevity by altering its tactics to the ever-shifting requirements of the customer base.
References
Almutairi, M.M.Q., (2023). The Impact Of Market Analysis On The Company Strategy. Journal of Positive School Psychology, pp.401-412.
Anderson, D.M., 2020. Design for manufacturability: how to use concurrent engineering to develop low-cost, high-quality products for lean production rapidly. CRC press.
AYYILDIZ, H., Tuncer, S.A., KALAYCI, M. and Aslan, R., (2022). Gram Stain Prediction with Machine Learning Techniques Using Biochemical Parameters in ICU Patients with Urinary Tract Infections. Ac?badem Üniversitesi Sa?l?k Bilimleri Dergisi, 13(2), pp.213-219.
Baldwin, P.A., Black, M.J., Newby, J.M., Brown, L., Scott, N., Shrestha, T., Cockayne, N., Tennant, J., Harvey, S.B. and Christensen, H., (2022). The Essential Network (TEN): Rapid development and implementation of a digital-first mental health solution for Australian healthcare workers during COVID-19. BMJ Innovations, pp.bmjinnov-2021.
Beckman (2019). Arnold O. Beckman.
Beckman Coulter (2022). Beckman Coulter Company Who We Are.
Beckman.com, (2023). About Beckman Coulter Life Sciences, Available at: https://www.beckman.com/about-us [Accessed on: 11 th December 2023]
Belkina, A.C., Roe, C.E., Tang, V.A., Back, J.B., Bispo, C., Conway, A., Chakraborty, U., Daniels, K.T., de la Cruz, G., Ferrer?Font, L. and Filby, A., (2023). Guidelines for establishing a cytometry laboratory. Cytometry Part A.
Bernstein, L. and Peterson, B., 2022. Managerial contracting: A preliminary study. Journal of Legal Analysis, 14(1), p.laac007.
Bonifay, A., Robert, S., Champagne, B., Petit, P.R., Eugène, A., Chareyre, C., Duchez, A.C., Vélier, M., Fritz, S., Vallier, L. and Lacroix, R., (2022). A new strategy to count and sort neutrophil?derived extracellular vesicles: Validation in infectious disorders. Journal of Extracellular Vesicles, 11(4), p.e12204.
Chalke, A., Nevgi, R., Karde, B. and Waghmare, S., (2022). Prevalence of Iron Deficiency and Iron Deficiency Anemia In Adolescent Girls in Tertiary Care Hospital.
Choi, H., Tashpulatova, Z., Moon, S.Y., Choi, J., Kim, J.Y. and Lee, S.M., 2022. Evaluation of the Beckman Coulter Access Procalcitonin Assay: analytical and clinical performance. Clinical Chemistry and Laboratory Medicine (CCLM), 60(2), pp.e50-e53.
Chu, E.C.P., Mok, S.T.K., Chow, I.S.W. and Chin, W.L., (2022). The opportunity to unlock the architecture of healthcare model: chiropractic care-at-home. Journal of Contemporary Chiropractic, 5(1), pp.44-49.
Coulter, B. (2022b). Sustainability at Beckman Coulter Life Sciences.
Frankenfield, J. (2019). Understanding Research and Development (R&D) Expenses.
Gupta, S. (2022). Sysmex and Abbott Laboratories are Leading Players in the Hematology Analyzers and Reagents Market.
Hoffmann, J., Thrun, M.C., Röhnert, M.A., von Bonin, M., Oelschlägel, U., Neubauer, A., Ultsch, A. and Brendel, C., (2023). Identification of critical hemodilution by artificial intelligence in bone marrow assessed for minimal residual disease analysis in acute myeloid leukemia: The Cinderella method. Cytometry Part A, 103(4), pp.304-312.
Islam, S., Teo, T., Kumarasiri, M., Slater, M., Martin, J.H., Wang, S. and Head, R., (2022). Combined in silico and in vitro evidence supporting an aurora a kinase inhibitory role of the anti-viral drug rilpivirine and an anti-proliferative influence on cancer cells. Pharmaceuticals, 15(10), p.1186.
Khiong, K., (2022). Impact and Challenges of Digital Marketing in Healthcare Industries during Digital Era and Covid-19 Pandemic. Journal of Industrial Engineering & Management Research, 3(5), pp.112-118.
Kretschmer, T., Leiponen, A., Schilling, M. and Vasudeva, G., (2022). Platform ecosystems as meta?organizations: Implications for platform strategies. Strategic Management Journal, 43(3), pp.405-424.
Labmate-online.com, (2023). Danaher to Acquire Beckman Coulter, Inc for $6.8 Billion, Available at: https://www.labmate-online.com/news/news-and-views/5/leica-microsystems-inc/danaher-to-acquire-beckman-coulter-inc-for-68-billion/14831#:~:text=With%20annual%20revenues%20of%20approximately,clinical%20settings%20around%20the%20world. [Accessed on: 11 th December 2023]
Lemoine, L., Malcus, C., Poitevin?Later, F., Venet, F., Monneret, G. and Gossez, M., (2022). Cross?sectional reassessment after 4 years of clinical routine use of AQUIOS CL for absolute T cell quantitation in a university hospital. Cytometry Part B: Clinical Cytometry, 102(5), pp.390-399.
Linkedin.com, (2023). Beckman Coulter Diagnostics, Available at: https://www.linkedin.com/company/beckman-coulter/ [Accessed on: 11 th December 2023]
Mahardhani, A.J., (2023). The Role of Public Policy in Fostering Technological Innovation and Sustainability. Journal of Contemporary Administration and Management (ADMAN), 1(2), pp.47-53.
Mosch, L., Fürstenau, D., Brandt, J., Wagnitz, J., Klopfenstein, S.A., Poncette, A.-S. and Balzer, F. (2022). The medical profession transformed by artificial intelligence: Qualitative study. DIGITAL HEALTH, 8, p.205520762211439.
Mülbert, P.O. and Sajnovits, A., 2022. Emerging ESG-Driven Models of Shareholder Collaborative Engagement. European Corporate Governance Institute-Law Working Paper, (668).
Otsu, M., Tanabe, Y., Iwakiri, A., Arima, K., Uchiyama, A., Yamamoto, M., Ohtani, S., Endo, H., Komoto, M. and Miyazaki, K., (2023). A report on a modified protocol for flow cytometry?based assessment of blood group erythrocyte antigens potentially suitable for analysis of weak ABO subgroups. Transfusion, 63(3), pp.463-469.
Ribeiro, F. de M. and Kruglianskas, I. (2020). Critical factors for environmental regulation change management: Evidence from an extended producer responsibility case study. Journal of Cleaner Production, 246, p.119013.
Robertson, L., 2021. Rebel Leadership: How to Thrive in Uncertain Times. Post Hill Press.
Saw, S.N. and Ng, K.H., (2022). Current challenges of implementing artificial intelligence in medical imaging. Physica Medica, 100, pp.12-17.
Schneider, G. (2019). WHAT IS YOUR LEADERSHIP STYLE?
Singh, G., Vinson, K.A., Jones, K., Gunsolus, B., Keever, J. and Keel, B.A., (2023). Long-term alliance for pathology equipment and technology acquisition: a paradigm shift for improved quality and efficiency. Laboratory Medicine, p.lmad071.
Terracciano, D., La Civita, E., Athanasiou, A., Liotti, A., Fiorenza, M., Cennamo, M., Crocetto, F., Tennstedt, P., Schiess, R., Haese, A. and Ferro, M., (2022). New strategy for the identification of prostate cancer: The combination of Proclarix and the prostate health index. The Prostate, 82(15), pp.1469-1476.
The Wall Street Transcript. (2019). Scott Garrett - Beckman Coulter, Inc. (bec).
Tieze, S.M., Chandra, S.S. and Vidyadhara, D.J., 2022. Subcellular fractionation for the isolation of synaptic components from the murine brain. JoVE (Journal of Visualized Experiments), (187), p.e64574.
Turner, S., D´ Lima, D., Sheringham, J., Swart, N., Hudson, E., Morris, S. and Fulop, N.J., (2022). Evidence use as sociomaterial practice? A qualitative study of decision-making on introducing service innovations in health care. Public Management Review, 24(7), pp.1075-1099.
Tzovara, I., Papadatou, I., Tzanoudaki, M. and Spoulou, V., (2022). Development of a novel flow cytometry method for detecting pneumococcal?specific B cells. Cytometry Part A, 101(7), pp.588-596.
Vergnolle, I., Ceccomarini, T., Canali, A., Rieu, J.B. and Vergez, F., (2023). Use of a hybrid intelligence decision tree to identify mature B?cell neoplasms. Cytometry Part B: Clinical Cytometry.
VUCETIC, Z. (2023). Importance of access to accurate diagnostic care.
World Benchmarking Alliance (2020). The impact of multinationals in developing countries in developing countries A framework for benchmarking Introduction: World Benchmarking Alliance 3.
Zhao, J., Mao, Z., Fedewa, S.A., Nogueira, L., Yabroff, K.R., Jemal, A. and Han, X. (2020). The Affordable Care Act and access to care across the cancer control continuum: A review at ten years. CA: A Cancer Journal for Clinicians, 70(3).
